CluePoints logo
Verified via Expert Interviews

CluePoints: Revenue, Valuation & Competitors

CluePoints company overview

Ownership
PE-backed
Employees
267
Investors
EQT
Revenue / FTE
$3••k

About

Risk-based quality management and data quality oversight software for pharmaceutical companies and contract research organizations to identify, visualize, manage, and document clinical trial data risks.
Verified via Expert Interviews

Expert Vetted Data

Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former CluePoints executives.

Ownership & Key Financials

Revenue

$8•m '••
1

Investors

EQT
'24

Revenue / FTE

$3••k '••
1

Ownership

PE-backed

FTEs

1
+31% CAGR
70
2020
117
2021
153
2022
205
2023
267
2024

Legal Disclaimer

The company profiles displayed here are abridged, indicative previews of the full, proprietary data available within the Dialectica Origin Platform, derived from confidential sources and expert-vetted research. This content is the exclusive Intellectual Property (IP) of Dialectica. Your access does not grant any rights to the data. Systematic copying, scraping, crawling, indexing, or extraction, whether by manual means, automated software, bots, or Large Language Models (LLMs), is strictly prohibited and violates our Terms of Use.

This information is provided 'as is' for promotional purposes only; Dialectica disclaims all liability for its accuracy, completeness, or any reliance placed upon it.